The Cephalosporin market is a segment of the Antibiotics market. Cephalosporins are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from a fungus called Cephalosporium and are divided into four generations based on their antibacterial activity. Cephalosporins are used to treat infections caused by Gram-positive and Gram-negative bacteria, including respiratory, urinary tract, skin, and soft tissue infections. Cephalosporins are widely used in both human and veterinary medicine. They are available in various formulations, including tablets, capsules, suspensions, and injections. The global Cephalosporin market is driven by the increasing prevalence of bacterial infections, the growing demand for generic drugs, and the increasing use of Cephalosporins in veterinary medicine. Some of the major companies in the Cephalosporin market include Pfizer, Merck, Sanofi, Novartis, GlaxoSmithKline, AstraZeneca, and Allergan. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
